NFKB1 and acute myeloid leukemia: High basal NRF2 activity in acute myeloid leukemia (AML) has been attributed to constitutive NF-κB-mediated upregulation of the NFE2L2 gene and is believed to be one cause of resistance to chemotherapy in AML cells (138).